These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 31201794

  • 1. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
    Patel SN, Storey PP, Pancholy M, Obeid A, Wibbelsman TD, Levin H, Hsu J, Garg SJ, Dunn JP, Vander JF.
    Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
    [Abstract] [Full Text] [Related]

  • 2. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
    Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E, DeCroos FC, Garg SJ, Hsu J.
    Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
    Mezad-Koursh D, Goldstein M, Heilwail G, Zayit-Soudry S, Loewenstein A, Barak A.
    Retina; 2010 May; 30(7):1051-7. PubMed ID: 20616683
    [Abstract] [Full Text] [Related]

  • 4. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Post-Injection Endophthalmitis (PIE) Study Team.
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [Abstract] [Full Text] [Related]

  • 5. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
    Xu K, Chin EK, Bennett SR, Williams DF, Ryan EH, Dev S, Mittra RA, Quiram PA, Davies JB, Parke DW, Johnson JB, Cantrill HL, Almeida DRP.
    Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
    [Abstract] [Full Text] [Related]

  • 6. MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
    Garg SJ, Dollin M, Storey P, Pitcher JD, Fang-Yen NH, Vander J, Hsu J, Post-Injection Endophthalmitis Study Team.
    Retina; 2016 Feb; 36(2):351-9. PubMed ID: 26200514
    [Abstract] [Full Text] [Related]

  • 7. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
    Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C, FRCR net (FRenCh Retina specialists net).
    Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
    [Abstract] [Full Text] [Related]

  • 8. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
    Moshfeghi AA, Rosenfeld PJ, Flynn HW, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, Albini TA, Lalwani GA, Kovach JL, Puliafito CA.
    Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
    [Abstract] [Full Text] [Related]

  • 9. Endophthalmitis following intravitreal injections.
    Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H.
    Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):499-505. PubMed ID: 22048244
    [Abstract] [Full Text] [Related]

  • 10. Management and Visual Outcomes of Acute Bacterial Endophthalmitis Following Intravitreal Injection of Contaminated Bevacizumab in a Single Day.
    Xu K, Mousa R, Loewenstein A, Barak A, Chin EK, Almeida DRP.
    Ophthalmic Surg Lasers Imaging Retina; 2020 Jun 01; 51(6):346-352. PubMed ID: 32579693
    [Abstract] [Full Text] [Related]

  • 11. Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic Cultures.
    Patel SN, Storey PP, Levin H, Pancholy M, Obeid A, Wibbelsman TD, Kuley B, Ho AC, Hsu J, Garg SJ, Vander JF, Dunn JP.
    Ophthalmol Retina; 2021 Jan 01; 5(1):16-22. PubMed ID: 32599176
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
    Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR, Koto T, Abbey AM, Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, Williams P, Okada AA, Inoue M, Shiraga F, Hirakata A, Shah CP, Prenner J, Garg S, Post-Injection Endophthalmitis (PIE) Study Group.
    Am J Ophthalmol; 2019 Mar 01; 199():200-208. PubMed ID: 30552891
    [Abstract] [Full Text] [Related]

  • 13. COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB.
    Bavinger JC, Yu Y, VanderBeek BL.
    Retina; 2019 Oct 01; 39(10):2004-2011. PubMed ID: 30312260
    [Abstract] [Full Text] [Related]

  • 14. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
    Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA.
    Retina; 2013 Oct 01; 33(7):1407-16. PubMed ID: 23492945
    [Abstract] [Full Text] [Related]

  • 15. Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.
    Leung EH, Kuriyan AE, Flynn HW, Miller D, Huang LC.
    Am J Ophthalmol; 2016 May 01; 165():16-22. PubMed ID: 26921804
    [Abstract] [Full Text] [Related]

  • 16. Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center.
    Modjtahedi BS, Finn AP, Barb SM, MacLachlan MJ, van Zyl T, Papakostas TD, Eliott D.
    Ophthalmol Retina; 2019 Jan 01; 3(1):61-72. PubMed ID: 30929817
    [Abstract] [Full Text] [Related]

  • 17. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
    Al-Rashaed S, Alsulaiman SM, Alrushood AA, Almasaud J, Arevalo JF.
    Middle East Afr J Ophthalmol; 2016 Jan 01; 23(1):60-3. PubMed ID: 26957840
    [Abstract] [Full Text] [Related]

  • 18. Stenotrophomonas maltophilia: An emerging entity for cluster endophthalmitis.
    Beri S, Shandil A, Garg R.
    Indian J Ophthalmol; 2017 Nov 01; 65(11):1166-1171. PubMed ID: 29133644
    [Abstract] [Full Text] [Related]

  • 19. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
    Goldberg RA, Flynn HW, Isom RF, Miller D, Gonzalez S.
    Am J Ophthalmol; 2012 Feb 01; 153(2):204-208.e1. PubMed ID: 22264943
    [Abstract] [Full Text] [Related]

  • 20. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.
    Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB.
    Ophthalmology; 2004 Aug 01; 111(8):1495-503; discussion 1503. PubMed ID: 15288977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.